Surgical Treatment and Radioembolization
90Y radioembolization supposes a useful downstaging strategy to reduce tumor burden and increase the proportion of patients eligible for radical treatments in the hepatocellular carcinoma management. Moreover, contralateral hypertrophy is one of the most important advantages of this tactic with compared to other transarterial treatments, and it could be effective not only in hepatocellular carcinoma but also in selected patients with liver metastases. Since these metastases are usually unresectable at initial diagnosis, this treatment has been increasingly used in salvage setting for these patients.
KeywordsLiver Metastasis Portal Vein Embolization Barcelona Clinic Liver Cancer Milan Criterion Contralateral Hypertrophy
- Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239(6):818, 25 (discussion 825–827)Google Scholar
- Fernandez-Ros N, Silva N, Bilbao JI, Iñarrairaegui M, Benito A, D’Avola D, et al (2013) Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB (Oxford). doi: 10.1111/hpb.12095
- Iñarrairaegui M, Pardo F, Bilbao JI, Rotellar F, Benito A, D’Avola D et al (2012) Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol 38(7):594–601PubMedCrossRefGoogle Scholar
- Khalaf H, Alsuhaibani H, Al-Sugair A, Al-Mana H, Al-Mutawa A, Al-Khadi Y, Al-Sebayel M (2010) Use of Yttrium-90 Microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report. Transpl Proc 42:994–998Google Scholar
- Rosenbaum CE, Verkooijen HM, Lam MG, Smits ML, Koopman M, van Seeters T et al (2013) Radioembolization for treatment of salvage patients with colorectal cancer liver metastases: a systematic review. J Nucl Med 54:1890–1895Google Scholar